[Skip to Content]
[Skip to Content Landing]
Images in Neurology
February 2007

Myelopathy as a Complication of Intrathecal Drug Infusion Systems

Author Affiliations
 

Copyright 2007 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2007

Arch Neurol. 2007;64(2):286-287. doi:10.1001/archneur.64.2.286

Our first case was a 63-year-old right-handed man who required a permanent intrathecal drug infusion system for intractable nonsurgical back pain in April 2002. The catheter was placed at L1-L2 and was threaded to the T9-T10 level. The patient was successfully treated with hydromorphone and bupivacaine. Slowly escalating pain and a fall preceded a 2-week rapid deterioration in ambulation. Bowel and bladder incontinence developed. The patient had paraparesis with a sensory level at T10. Cerebrospinal fluid examination revealed a mild lymphocytic pleocytosis. Cerebrospinal fluid and catheter tip cultures revealed no growth. Magnetic resonance imaging (MRI) of the spine revealed increased signal and intramedullary enhancement at T9-T10, corresponding to the level of the catheter tip (Figure 1A). Magnetic resonance imaging 6 months later showed resolution of the changes in the thoracic spinal cord (Figure 1B). Two years after the event, the patient was able to walk with assistance devices.

×